Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple daily doses of IM-250 in healthy volunteers.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519482-22-00

Acronym

IM-102

Enrollment

Registered

2025-04-23

Start date

2025-04-30

Completion date

2025-06-27

Last updated

2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026